Cidara Therapeutics

About Cidara Therapeutics

Cidara Therapeutics is focused on developing targeted immunotherapies to save lives and improve the standard of care for patients facing serious diseases.

Products & Services

Cloudbreak Technology:A platform that creates 'single molecule cocktails' by coupling targeted small molecules and peptides to a human antibody fragment (Fc), resulting in drug-Fc conjugate (DFC) immunotherapies designed to inhibit specific disease targets while engaging the immune system.

Influenza Program:A targeted immunotherapy program under the Cloudbreak platform focusing on influenza.

Specialties

Targeted Immunotherapy Drug-Fc Conjugate (DFC) Immunotherapies Influenza Treatment Immuno-Oncology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 402500000 MR: - FA: $402.5 million FAN: 402500000	D: 2025-06-26 FD: 2025-06-26	4 investors
2	RT: Public Offering T: - FT: Public Offering	A: 350000000 MR: - FA: $350.0 million FAN: 350000000	D: 2025-06-24 FD: 2025-06-24	4 investors
3	RT: Public Offering T: - FT: Public Offering	A: 250000000 MR: - FA: $250.0 million FAN: 250000000	D: 2025-06-23 FD: 2025-06-23	4 investors
4	RT: Private Placement T: - FT: Private Placement	A: 105000000 MR: - FA: $105 million FAN: 105000000	D: 2024-11-21 FD: 2024-11-21	8 investors
5	RT: Milestone Payment T: - FT: Milestone Payment	A: 11140000 MR: - FA: 11.14 million FAN: 11140000	D: 2024-02-12 FD: 2024-02-12	1 investors
6	RT: Public Offering T: - FT: Public Offering	A: 19500000 MR: - FA: approximately $19.5 million FAN: 19500000	D: 2023-03-07 FD: 2023-03-07	1 investors
7	RT: Public Offering T: - FT: Public Offering	A: 17500000 MR: - FA: approximately $17.5 million FAN: 17500000	D: 2023-03-03 FD: 2023-03-03	1 investors

Public Offering Latest

2025-06-26

$402.5M

4 investors (Pro only)

Public Offering 2025-06-24

$350.0M

Public Offering 2025-06-23

$250.0M

View 6 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jeffrey Stein

President and Chief Executive Officer

LinkedIn (Pro only)

N

Nicole Davarpanah

Chief Medical Officer

A

Allison Lewis

Senior Vice President, People and Culture

LinkedIn (Pro only)

C

Corrina Pavetto

Senior Vice President, Clinical Development

F

Frank Karbe

Chief Financial Officer

L

Les Tari

Chief Scientific Officer

View 14 more team members with Pro

Unlock Full Team Directory

Recent News